ChemicalBook > CAS DataBase List > Tofacitinib Impurity 45

Tofacitinib Impurity 45

Product Name
Tofacitinib Impurity 45
CAS No.
2407039-29-4
Chemical Name
Tofacitinib Impurity 45
Synonyms
CP-690550 N-Hydroxyl;Tofacitinib Impurity 45;Tofacitinib Impurity 172;(3R,4R)-3-[(7-Hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-1-piperidinepropanenitrile;1-Piperidinepropanenitrile, 3-[(7-hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-
CBNumber
CB03360222
Molecular Formula
C16H20N6O2
Formula Weight
328.38
MOL File
2407039-29-4.mol
More
Less

Tofacitinib Impurity 45 Property

Melting point:
>144°C (dec.)
Boiling point:
625.5±65.0 °C(Predicted)
Density 
1.39±0.1 g/cm3(Predicted)
storage temp. 
-20°C Freezer, Under inert atmosphere
solubility 
DMSO (Slightly), Methanol (Slightly, Sonicated)
form 
Solid
pka
6.04±0.60(Predicted)
color 
Light Brown to Brown
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Tofacitinib Impurity 45 Chemical Properties,Usage,Production

Uses

CP-690550 N-Hydroxyl is an impurity of CP-690550 (C781350), a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis.

Tofacitinib Impurity 45 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Tofacitinib Impurity 45 Suppliers

China 19 United States 2 Global 21
Standardpharm Co. Ltd.
Tel
86-714-3992388
Email
overseasales1@yongstandards.com
Country
United States
ProdList
14332
Advantage
58
Cato Research Chemicals Inc.
Tel
020-81215950 4000-868-328
Email
customer@uwalab.com
Country
United States
ProdList
10404
Advantage
58

2407039-29-4, Tofacitinib Impurity 45Related Search:

(3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity Tofacitinib Impurity 36 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE Tofacitinib Related Compound Tofacitinib Impurity 2

  • Tofacitinib Impurity 45
  • CP-690550 N-Hydroxyl
  • (3R,4R)-3-[(7-Hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-1-piperidinepropanenitrile
  • 1-Piperidinepropanenitrile, 3-[(7-hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-
  • Tofacitinib Impurity 172
  • 2407039-29-4